UCSF Helen Diller Family Comprehensive Cancer Center - People

About Us

News & Events

Medical Care

Support Services

People

Health Care Professionals

Researchers & Staff

Media Professionals

BADRINATH KONETY, MD, MBA

Associate Professor, Urology and Epidemiology/Biostatistics, UCSF

CONTACT

(415) 353-7171 (appts)
(415) 885-7443 (fax)

Box 1695, UCSF; San Francisco, CA 94143-1695

additional websites:

UCSF Physician Referral Directory

EDUCATION
St. Joseph's College, Bangalore Univ., India, Pre-Univ. Certificate, 1982-1984, Science M.S. Ramaiah Medical College, Bangalore Univ. India, MBBS, 1984-1990 University of Pittsburgh Katz School of Business, MBA, 1998-2000, Business
PROFESSIONAL EXPERIENCE
1989-1990	Rotating Internship, M.S. Ramaiah Medical College and Teaching Hospital, Bangalore, India.
1991-1992	Research Fellow, Department of Urology, Veterans Administration Medical Center-University of California San Francisco.
1992-1994	Resident in General Surgery, University of Pittsburgh, PA.
1994-1998	Resident in Urology, University of Pittsburgh, PA.
1998- 2000	Fellow, Dept. of Urology/University of Pittsburgh Cancer Institute, Univ. of Pittsburgh, PA.
2000- 2001	Fellow, Dept. of Urology, Memorial Sloan Kettering Cancer Center, New York, NY.
2001- 2005	Assistant Professor, Dept. of Urology, University of Iowa
August 2005- present	Associate Professor, Departments of Urology and Epidemiology/Biostatistics, University of California, San Francisco
HONORS & AWARDS
1992	ACMI/Joseph MacArthy Essay Contest, AUA, Western Section Annual Meeting 1st Prize (co-author).
1995	Amercian College of Surgeons-Western Pennsylvania Chapter, Annual Residents Day; Prize paper (Basic Science).
1995	American College of Surgeons Residents Day; Prize Paper (Basic Science).
1996	Pittsburgh Urologic Association Annual Residents Day; 2nd Prize.
1996	American College of Surgeons Residents Day; 1st Prize Basic Science.
1997	Pittsburgh Urologic Association Annual Residents Day; 1st Prize.
1997	American College of Surgeons Residents Day; Prize Paper (Clinical).
1998	Frederick N. Schwentker Endowment Award for Research in Urology.
1998	American Foundation for Urologic Disease and Bladder Health Council Research Scholar.
1998	Pfizer Scholars in Urology Award.
1998	UPCI Director's Award for Scientific Excellence and Potential.
1999	Residents Essay Contest, American Urologic Association Northwest Section 50th Annual Meeting; 1st Prize.
2004	Ambrose Reed Socioeconomic Essay, American Urologic Association
2004	American Urologic Association/European Urologic Association Exchange Fellow
2006	Winner, Geriatrics Prize Essay Contest, American Urologic Association
SELECTED PUBLICATIONS
(of a total of 77):
Dahiya R, Boyle B, Goldberg BC, Yoon WH, Konety B, Chen K, Yen BT, Blumenfeld W, Narayan P. Metastasis associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines. Biochem. Cell Biol. 70: 548-554, July 1992.
Narayan P, Konety B, Aslam K, Schmidt RA, Aboseif S, Blumenfeld W. Neuroanatomy of the external urethral sphincter - implications for continence preservation during radical prostate surgery. J. Urol. 153(2): 337-341, 1995.
Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P. Citrate as an in vivo marker to discriminate benign prostatic hyperplasia and normal prostate. peripheral zone: detection via localized proton spectroscopy. Urology 45(3): 459-466, 1995.
Getzenberg RH, Konety BR, Oeler TA, Quigley MM, Hakam A, Becich MJ, Bahnson RR. Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56:1690-1694, 1996.
Konety B, Naraghi R, Gooding W, ODonnell WF, Bahnson RR. Evaluation of computerized tomography for staging of clinically localized adenocarcinoma of the prostate. Urol. Oncol. 2:14-19, 1996.
Konety B, Schwartz GG, Acierno JS, Becich MJ, Getzenberg RH. The role of vitamin D in normal prostate growth and differentiation. Cell Growth and Diff. 7:1563-1570, 1996.
Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology 50:999-1006, 1997.
Konety BR, Nangia AK, Nguyen T-ST, Veitmeier BN, Dhir R, Acierno JS, Becich MJ, Hrebinko R, Getzenberg RH. Identification of nuclear matrix alterations associated with renal cell carcinoma. J. Urol. 159(4):1359-1363, 1998.
Nangia AK, Butcher J, Konety BR, Getzenberg RH. Association of vitamin D receptors with the nuclear matrix of human and rat genitourinary tissues. J. Steroid Biochem. Molec. Biol. 66:241-246, 1998.
Krill D, Stoner J, Konety BR, Becich MJ, Getzenberg RH. Differential effects of vitamin D on normal human prostatic epithelial and stromal cells in primary culture. Urology 54:171-177, 1999.
Konety BR, Nangia AK, Nguyen TST, Thomas A, Getzenberg RH. Effect of pre-natal vitamin D (calcitriol) exposure on the growth and development of the prostate and premature death. Prostate 41(3):181-189, 1999.
Konety BR, Nguyen TST, Brenes G, Lewis N, Saul M, Nelson JB, Getzenberg RH. Evaluation of the effect of spinal cord injury (SCI) on serum PSA levels. Urology 56(1):82-86, 2000.
Konety BR, Nguyen TST, Brenes G, Sholder A, Lewis N, Bastacky S, Potter DM, Getzenberg RH. Clinical utility of the novel marker, BLCA-4 for the detection of bladder cancer. J. Urol. 164:634-639, 2000.
Konety BR, Leman E, Vietmeier BN, Arlotti JA, Dhir R, Getzenberg RH. In vitro and in vivo effects of vitamin D (calcitriol) administration on the normal neonatal and pre-pubertal prostate. J. Urol. 164:1812-1818, 2000.
Konety BR, Nguyen TS, Brenes G, Sholder A, Lewis N, Bastacky S, Potter DM, Getzenberg RH. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer. J. Urol. 164:634-639, 2000.
Konety BR, Nguyen TS, Dhir R, Day RS, Becich MJ, Stadler WM, Getzenberg RH. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4. Clin. Cancer Res. 6:2618-2625, 2000.
Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen T-ST, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J. Urol. 165:253-258, 2001.
Konety BR, Somogi G, Atan A, Muindi J, Chancellor MB, Getzenberg RH. Evaluation of intra-prostatic metabolism of 1,25 dihydroxy vitamin D3 (Calcitriol) using a microdialysis technique. Urology 59:947-952, 2002.
Bunker CH, Patrick AL, Konety BR, Brufsky AM, Vivas CA, Dhir R, Becich MJ, Trump DL, Kuller LH. High prevalence of PSA screening detected prostate cancer among Afro-Caribbeans: Preliminary results from the Tobago prostate cancer survey. Cancer Epidemiol. Biomarkers Prev. 11(8):726-729, 2002.
Konety BR, Joslyn SA, OÕDonnell MA. Extent of Pelvic Lymphadenectomy and its Impact on Outcome in Patients Diagnosed with Bladder Cancer: Analysis of Data from the Surveillance, Epidemiology, and End Results (SEER) Program Database. J. Urol. 169:946-950, 2003.
Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J. Urol. 170:1765-1771, 2003
Joudi FN, Smith BJ, OÕDonnell MA, Konety BR. Contemporary management of superficial bladder cancer in the United States- a pattern of care analysis. Urology 62:1083-1088, 2003.
Konety BR, Eastham JA, Reuter VE, Scardino PT, Donat MS, Dalbagni G, Russo P, Schwartz L, Kantoff PW, Scher H, Kelly WK. Feasibility of radical prostatectomy following neo-adjuvant chemo-hormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. J. Urol. 171:709-713, 2004.
VanLe TS, Myers J, Konety BR, Barder T, Getzenberg RH. Functional Characterization of the Bladder Cancer Marker, BLCA-4. Clin. Cancer Res. 10:1384-1391, 2004.
Konety BR, Allareddy V, Dhawan V, OÕDonnell MA. Association between volume and charges for most frequently performed ambulatory and non-ambulatory surgery for bladder cancer: is more cheaper? J. Urol. 172:1056-1061, 2004
Rippentrop J, Joslyn SA, Konety BR. Squamous Cell Carcinoma of the Penis: Evaluation of SEER Data on Race and Marital History. Cancer 101:1357-1363, 2004.
Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long term bladder cancer survivors. Cancer 106:2355-2362, 2006.
Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Igawa M, Konety BR, Dahiya R. Wnt inhibitory factor-1 plays an important role in pathobiology of bladder cancer through aberrant canonical Wnt/b-catenin pathways. Clin. Cancer Res.12:383-391, 2006.
Lubaroff D, Konety BR, Link B, Ratliff T, Madsen T, Shannon M, Ecklund D, Williams RD. Clinical Protocol: A Phase I Study of an Adenovirus/PSA Vaccine in Men with Metastatic Prostate Cancer. Hum. Gene Ther. 17:220-229, 2006.
Konety BR, Allareddy V, Herr H. Complications following radical cystectomy: analysis of population based data. Urology 68:58-64, 2006.
Joslyn SA, Konety BR. The impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68:121-125, 2006.
Allareddy V, Konety BR. Characteristics of Patients and Predictors of In-Hospital Mortality Following Hospitalization for Head and Neck Cancers. Cancer 106:2382-2388, 2006.
Konety BR, Allareddy V, Modak S, Smith B. Mortality Following Major Surgery for Urologic Cancers in Specialized Urology Hospitals: Are They Any Better? J. Clin. Oncol.24:2006-2012, 2006.
12/7/06

This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device. Please upgrade your browser.